World's Largest Resource for Cardiovascular Perfusion

Perfusion StaffingPerfusion Staffing
   +1 888-499-5672Login
Perfusion NewswireBiologics ZoneIntraoperative Use of Autologous Platelet-rich and Platelet-poor Plasma for Orthopedic Surgery Patients

Intraoperative Use of Autologous Platelet-rich and Platelet-poor Plasma for Orthopedic Surgery Patients

Biologics Zone, Main Zone, Mobile Zone

Abstract: As use of autologous platelet-rich plasma (PRP) and platelet-poor plasma (PPP) increases for intraoperative care of a variety of patients, it is important for perioperative nurses to recognize their benefits. Autologous PRP may decrease postoperative drainage, reduce narcotic requirements, and facilitate an early return to mobility. Postoperatively, patients should experience fewer complications, recover more rapidly, and have a reduced hospital stay. This article defines autologous PRP and PPP, describes processing and application of PRP and PPP, and reports clinical outcomes of the use of platelet concentrate for a group of patients who underwent total knee arthroplasty.

Leave a Reply

You may also like
COVID-19, Perfusion Zone, Tiny Perfusion Letter

COVID Convalescence—A Boon or Bane in Cardiac Surgery?: A “Second Hit” Hypothesis

A “convalescent COVID-19” patient with “first hit” at primary infection, encountering a “second hit” of surgery and perioperative insults, might have a hyperimmune response. This “second hit” hypothesis should be considered when COVID-19 convalescent (COVID-19 symptomatic or asymptomatic) patients undergo cardiac surgery and present with unusual complicatio

Join TodayJoin Today